Latest Breaking News On - Scientific resources - Page 2 : comparemela.com

Tiny particles offer big clues toward predicting Alzheimer s decades in advance

Tiny particles offer big clues toward predicting Alzheimer s decades in advance
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesKendall van keuren jensenTimothy whitsettEric alsopJoanna paladeTgen neurogenomics division staff scientist joanna paladeTgen neurogenomics divisionUniversity of californiaInstitutional researchTranslational genomics research institute tgenShiley marcos alzheimer disease research centerTranslational genomics research instituteShiley marcos alzheimerDisease research centerNeurogenomics division

Kymera Therapeutics Presents Interim Results from STAT3 Degrader Phase 1 Clinical Trial at American Society of Hematology Annual Meeting

STAT3 Degrader KT-333 showed early signs of antitumor activity across liquid and solid tumors, including major responses in cutaneous T-cell lymphoma and Hodgkin’s lymphoma Robust STAT3.

United statesSan diegoTodd cooperJared gollobJustine koenigsbergAditi shastriExchange commissionMontefiore medical centerCorporate affairsKymera therapeutics incAmerican society of hematologyAlbert einstein college of medicineBoston globeAmerican societyAnnual meetingChief medical officer

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesBrent pfeiffenbergerMelissa forst maghan meyersKrish patelInternational numberSwedish cancer instituteDrug administrationExchange commissionAmerican society of hematologyLymphoma programTherapeutics presents initial dataMulti dosing strategyDose levelAmerican societyAnnual meeting

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoMaghan meyersKrish patelBrent pfeiffenbergerMelissa forstAmerican society of hematologyCentury therapeutics incInternational numberLymphoma programSwedish cancer instituteDrug administrationExchange commissionGlobenewswire incDose levelAnnual meeting

Century Therapeutics Presents Initial Data from CNTY-101

Century Therapeutics Presents Initial Data from CNTY-101
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesBrent pfeiffenbergerKrish patelSwedish cancer instituteInternational numberDrug administrationAmerican society of hematologyExchange commissionLymphoma programDose levelAmerican societyAnnual meetingDerived allogeneicTumor microenvironment changes associatedScientific resources